Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients

Objective: To evaluate the effects of HIV-associated neurocognitive impairment on caudate blood flow and volume. Methods: The authors performed continuous arterial spin labeled MRI on 42 HIV+ patients (23 subsyndromic and 19 HIV neurosymptomatic) on highly active antiretroviral therapy and 17 seronegative controls. They compared caudate blood flow and volume among groups. Results: A stepwise decrease in both caudate blood flow and volume was observed with increasing HIV-associated neurocognitive impairment. Compared with seronegative controls, baseline caudate blood flow was reduced in HIV+ neurosymptomatic patients (p = 0.001) with a similar decreasing trend for subsyndromic HIV+ patients (p = 0.070). Differences in caudate volume were observed only for neurosymptomatic HIV+ patients compared with controls (p = 0.010). A Jonckheere–Terpstra test for trends was significant for both caudate blood flow and volume for each of the three subgroups. Pearson product moment correlation coefficients were not significant between caudate blood flow and volume for each group. Conclusions: Decreasing trends in caudate blood flow and volume were associated with significantly increasing HIV-associated neurocognitive impairment (HNCI), with the greatest decreases observed for more severely impaired patients. However, reductions in caudate blood flow and volume were poorly correlated. Changes in residual caudate blood flow may act as a surrogate biomarker for classifying the degree of HNCI.

[1]  S C Strother,et al.  Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  C. Hilton.  General paralysis of the insane and AIDS in old age psychiatry: epidemiology, clinical diagnosis, serology and ethics—the way forward , 1998, International journal of geriatric psychiatry.

[3]  J. Becker,et al.  Dementia in AIDS patients , 1993, Neurology.

[4]  John A Detre,et al.  Precision of the CASL‐perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories , 2003, Journal of magnetic resonance imaging : JMRI.

[5]  K. Marder,et al.  Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes , 2001, Neurology.

[6]  L. Wilkins.  Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder , 1996, Neurology.

[7]  J. Detre,et al.  Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. , 2005, Radiology.

[8]  M. Schnall,et al.  Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla , 2002, Magnetic resonance in medicine.

[9]  J. Detre,et al.  Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. , 1998, Radiology.

[10]  Laurent Itti,et al.  Changes in cerebral metabolism are detected prior to perfusion changes in early HIV‐CMC: A coregistered 1H MRS and SPECT study , 2000, Journal of magnetic resonance imaging : JMRI.

[11]  Comparison of transcranial Doppler flow velocity and cerebral blood flow during focal ischemia in rabbits. , 1999, Ultrasound in medicine & biology.

[12]  M. Avison,et al.  Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? , 2002, Trends in Neurosciences.

[13]  H. Hefter,et al.  Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. , 2000, Archives of neurology.

[14]  Robert K. Heaton,et al.  Predictive Validity of Global Deficit Scores in Detecting Neuropsychological Impairment in HIV Infection , 2004, Journal of clinical and experimental neuropsychology.

[15]  J. McArthur.  HIV dementia: an evolving disease , 2004, Journal of Neuroimmunology.

[16]  G. Pearlson,et al.  Altered cortical blood flow in HIV‐seropositive individuals with and without dementia: a single photon emission computed tomography study , 1994, AIDS.

[17]  I. Grant,et al.  Initial Validation of a Screening Battery for the Detection of HIV-Associated Cognitive Impairment , 2004, The Clinical neuropsychologist.

[18]  I Grant,et al.  Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. , 1994, Psychosomatic medicine.

[19]  I. Grant,et al.  Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders , 2004, Annals of neurology.

[20]  Oliver Speck,et al.  Perfusion MRI detects rCBF abnormalities in early stages of HIV–cognitive motor complex , 2000, Neurology.

[21]  K. Goodkin,et al.  Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. , 1997, Neuroimaging clinics of North America.

[22]  Carla J. Reicks,et al.  The impact of HIV-associated neuropsychological impairment on everyday functioning , 2004, Journal of the International Neuropsychological Society.

[23]  A. J. Kumar,et al.  Patterns of cerebral atrophy in HIV–1–infected individuals , 1992, Neurology.

[24]  F. Gerstenbrand,et al.  Single photon emission computed tomography in AIDS dementia complex. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  J. Mendelson,et al.  A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  M. Avison,et al.  The blood brain barrier in HIV infection. , 2004, Frontiers in bioscience : a journal and virtual library.

[27]  C. Kirsch,et al.  Functional and Morphological Findings in Early and Advanced Stages of HIV Infection: a Comparison of 99mTc-HMPAO SPECT with CT and MRI Studies , 1990, Nuklearmedizin.

[28]  E. Masliah,et al.  Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder , 1999, Brain pathology.

[29]  F. Schmitt,et al.  Neuroimaging correlates of HIV-associated BBB compromise , 2004, Journal of Neuroimmunology.

[30]  E. Aylward,et al.  Regional brain atrophy in HIV‐1 infection: association with specific neuropsychological test performance , 1993, Acta neurologica Scandinavica.

[31]  C. Fennema-Notestine,et al.  Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. , 2004, Archives of neurology.

[32]  A. Guimarães,et al.  Increased cerebral blood volume in HIV‐positive patients detected by functional MRI , 1998, Neurology.

[33]  G D Pearlson,et al.  Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. , 1995, The American journal of psychiatry.

[34]  Sohil H. Patel,et al.  Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. , 2002, AJNR. American journal of neuroradiology.

[35]  Daniel Y. Kimberg,et al.  Empirical analyses of null-hypothesis perfusion FMRI data at 1.5 and 4 T , 2003, NeuroImage.

[36]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[37]  R. Herning,et al.  Antiviral Medications Improve Cerebrovascular Perfusion in HIV+ Non‐Drug Users and HIV+ Cocaine Abusers , 2001, Annals of the New York Academy of Sciences.

[38]  K. Marder,et al.  Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment , 2003, Neurology.

[39]  Joseph A Maldjian,et al.  Continuous Arterial Spin Labeled Perfusion Magnetic Resonance Imaging in Patients before and after Carotid Endarterectomy , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.